ANALISIS OPTIMASI STRUKTUR MODAL PADA PERUSAHAAN SUB SEKTOR FARMASI YANG TERDAFTAR DI BEI PERIODE 2019-2023
DOI:
Abstract Views:
114 times
PDF Downloads:
115 times
Abstract
Optimal capital structure is one of the policies of a company, in which case if the company can optimize its capital structure will have a positive impact on the company's financial performance. Companies that can optimize their capital structure will have an impact on the value of the company, so that it will be an attraction for an investor in investing in the company. Therefore, capital structure is considered important for a company. This study aims to measure the optimal capital structure in Pharmaceutical Sub-Sector Companies Listed on the IDX in 2019 - 2023. The population in this study were Pharmaceutical Sub-Sector Companies Listed on the IDX, using purposive sampling method which finally obtained four companies as samples. This study uses data analysis methods in the form of Capital Structure Composition Ratio, Cost of Capital, Weighted Average Cost of Capital, Tobin's Q Ratio. The results in this study found that in 2021 PT Darya Varia Laboratoria Tbk (DVLA) and in 2019 PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO) could maximize their capital structure. And in companies with the code KLBF and PEHA during the five years of observation have not been able to optimize their capital structure.
Downloads
References
Bayunitri, B. I., & Malik, T. A. (2015). Analisis Faktor-Faktor Yang Mempengaruhi Struktur Modal Pada Perusahaan Manufaktur Bunga Indah Bayuni tri. STAR: Study & Accounting Research, XII(1), 49–58.
Dewi, I. R. et al. (2014). Pengaruh Struktur Modal Terhadap Nilai Perusahaan Melalui Corporate Governance. Jurnal Administrasi Bisnis, 17(1), 1–9.
Dwi, C. (2023a). 9 Saham Farmasi Beterbangan, Efek Covid-19 Naik Lagi? CNBC Indonesia. https://www.cnbcindonesia.com/market/20231219233036-17-498725/9-saham-farmasi-beterbangan-efek-covid-19-naik-lagi
Dwi, C. (2023b). Pandemi Covid-19 Usai, Begini Kinerja Saham Kesehatan di 2023. CNBC Indonesia. https://www.cnbcindonesia.com/market/20231221000956-17-499060/pandemi-covid-19-usai-begini-kinerja-saham-kesehatan-di-2023
Ganevia, N. R. et al. (2022). Pengaruh Leverage, Ukuran Perusahaan Dan Kepemilikan Manajerial Terhadap Konservatisme Akuntansi. Jurnal Bisnis Terapan, 6(2), 117–129. https://doi.org/10.24123/jbt.v6i2.5096
Jegers, M. (2018). Capital structure. Handbook of Research on Nonprofit Economics and Management: Second Edition, 15(2), 87–96. https://doi.org/10.4324/9781003073796-9
Kontan. (2022). Airlangga: Industri Kesehatan Menjadi Fokus Pemerintah Saat Ini. Kontan. https://nasional.kontan.co.id/news/airlangga-industri-kesehatan-menjadi-fokus-pemerintah-saat-ini
Margaretha, F. (2007). Manajemen Keuangan Bagi Industri Jasa. Grasindo. https://books.google.co.id/books?id=YNNha_x4sUQC&newbks=1&newbks
Martilova, N. (2023). Pengaruh Struktur Modal, Profitabilitas Dan Ukuran Perusahaan Terhadap Nilai Perusahaan. Jurnal Ilmiah Manajemen, Bisnis Dan Kewirausahaan, 3(1), 153–175. https://doi.org/10.55606/jurimbik.v3i1.465
Prajanto, A., & Pratiwi, R. D. (2017). Analisis Nilai Perusahaan Manufaktur Di Indonesia Dari Perspektif Kinerja Keuangan. Jurnal Akuntansi Indonesia, 6(1), 13. https://doi.org/10.30659/jai.6.1.13-28
Primiwardani, R. (2011). Penetapan Struktur Modal Yang Optimal Dalam Rangka Meningkatkan Nilai Perusahaan (Studi Pada PT. Aqua Golden Mississipi, Tbk dan Anak Perusahaan,. 9(2), 1–8. http://repository.ub.ac.id/id/eprint/115181/
Riyanto, B. (2010). Dasar-Dasar Pembelanjaan Perusahaan (4th ed.). BPFE YOGYAKARTA. https://library.inais.ac.id/opac/detail-opac?id=762#tab_12
Ross, S. A., Westerfield, R. W., & Jordan, B. D. (2009). Pengantar Keuangan Perusahaan. Salemba Empat.
Sudiyanto, B. & P. (2010). Tobin’s Q dan Altman Z-Score Sebagai Indikator Pengukuran Kinerja Perusahaan. 2(1), 9–21.
Sutrisno, E. (2021). Potensi Besar Industri Kesehatan Dalam Negeri. Indonesia.Go.Id. https://indonesia.go.id/kategori/editorial/2811/potensi-besar-industri-kesehatan-dalam-negeri
Wijayanto, E., & Putri, A. N. (2018). Analisis Pengaruh Rasio Likuiditas, Rasio Leverage, Rasio Profitabilitas Dan Kepemilikan Manajerial Terhadap Kebijakan Dividen. Jurnal Aktual Akuntansi Keuangan Bisnis Terapan (AKUNBISNIS), 1(2), 105–118. https://doi.org/10.32497/akunbisnis.v1i2.1223
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Ciptaan disebarluaskan di bawah Lisensi Creative Commons Atribusi-NonKomersial-BerbagiSerupa 4.0 Internasional.
-
Articles published in Jurnal Bisnis Terapan are licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits anyone to copy, transform, or redistribute articles for any lawful purpose in any medium, provided appropriate credit is given to the original author(s) and Jurnal Bisnis Terapan is recognized as its original publisher. A link to this license should also be provided. Any derivative work of an article published in Jurnal Bisnis Terapan must also be shared under the same (or compatible) license.
-
Both copyright and publishing rights on articles are retained by the respective author(s), without restrictions. Only a non-exclusive license is granted to Jurnal Bisnis Terapan to publish the article and identify itself as its original publisher.
